Argent Trust Co’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $12.3M | Buy |
25,095
+1,943
| +8% | +$1.05M | 0.42% | 53 |
|
|
2025
Q4 | $13.4M | Buy |
23,152
+1,581
| +7% | +$894K | 0.46% | 48 |
|
|
2025
Q3 | $10.5M | Buy |
21,571
+1,125
| +6% | +$524K | 0.37% | 67 |
|
|
2025
Q2 | $8.29M | Sell |
20,446
-1,522
| -7% | -$636K | 0.31% | 69 |
|
|
2025
Q1 | $10.9M | Buy |
21,968
+28
| +0.1% | +$15.2K | 0.45% | 54 |
|
|
2024
Q4 | $11.4M | Sell |
21,940
-643
| -3% | -$354K | 0.47% | 51 |
|
|
2024
Q3 | $14M | Buy |
22,583
+31
| +0.1% | +$18.4K | 0.58% | 42 |
|
|
2024
Q2 | $12.5M | Buy |
22,552
+551
| +3% | +$316K | 0.55% | 43 |
|
|
2024
Q1 | $12.8M | Buy |
22,001
+569
| +3% | +$319K | 0.58% | 43 |
|
|
2023
Q4 | $11.4M | Sell |
21,432
-141
| -0.7% | -$68.2K | 0.57% | 42 |
|
|
2023
Q3 | $10.9M | Buy |
21,573
+197
| +0.9% | +$105K | 0.6% | 39 |
|
|
2023
Q2 | $11.2M | Buy |
21,376
+1,280
| +6% | +$691K | 0.6% | 37 |
|
|
2023
Q1 | $11.6M | Buy |
20,096
+222
| +1% | +$125K | 0.73% | 30 |
|
|
2022
Q4 | $10.9M | Buy |
19,874
+179
| +0.9% | +$94.8K | 0.72% | 32 |
|
|
2022
Q3 | $9.99M | Buy |
19,695
+16
| +0.1% | +$8.95K | 0.72% | 31 |
|
|
2022
Q2 | $10.7M | Sell |
19,679
-80
| -0.4% | -$44K | 0.73% | 32 |
|
|
2022
Q1 | $11.7M | Sell |
19,759
-293
| -1% | -$168K | 0.71% | 33 |
|
|
2021
Q4 | $13.4M | Buy |
20,052
+83
| +0.4% | +$51.8K | 0.78% | 28 |
|
|
2021
Q3 | $11.4M | Buy |
19,969
+685
| +4% | +$376K | 0.73% | 33 |
|
|
2021
Q2 | $9.73M | Sell |
19,284
-266
| -1% | -$126K | 0.64% | 41 |
|
|
2021
Q1 | $8.92M | Buy |
19,550
+537
| +3% | +$256K | 0.63% | 44 |
|
|
2020
Q4 | $8.86M | Sell |
19,013
-191
| -1% | -$89.6K | 0.68% | 41 |
|
|
2020
Q3 | $8.48M | Sell |
19,204
-185
| -1% | -$76.4K | 0.75% | 37 |
|
|
2020
Q2 | $7.03M | Buy |
19,389
+68
| +0.4% | +$22.8K | 0.66% | 40 |
|
|
2020
Q1 | $5.48M | Buy |
19,321
+62
| +0.3% | +$19.6K | 0.62% | 41 |
|
|
2019
Q4 | $6.26M | Buy |
19,259
+438
| +2% | +$133K | 0.56% | 47 |
|
|
2019
Q3 | $5.48M | Buy |
18,821
+1,547
| +9% | +$443K | 0.53% | 51 |
|
|
2019
Q2 | $5.07M | Buy |
17,274
+567
| +3% | +$156K | 0.51% | 51 |
|
|
2019
Q1 | $4.57M | Sell |
16,707
-4,211
| -20% | -$1.05M | 0.48% | 54 |
|
|
2018
Q4 | $4.68M | Buy |
20,918
+550
| +3% | +$129K | 0.55% | 47 |
|
|
2018
Q3 | $4.93M | Sell |
20,368
-895
| -4% | -$206K | 0.57% | 45 |
|
|
2018
Q2 | $4.4M | Buy |
21,263
+11,898
| +127% | +$2.53M | 0.54% | 48 |
|
|
2018
Q1 | $1.93M | Sell |
9,365
-467
| -5% | -$98K | 0.55% | 48 |
|
|
2017
Q4 | $1.87M | Sell |
9,832
-215
| -2% | -$41.2K | 0.73% | 35 |
|
|
2017
Q3 | $1.9M | Sell |
10,047
-91
| -0.9% | -$16.5K | 0.75% | 33 |
|
|
2017
Q2 | $1.77M | Sell |
10,138
-674
| -6% | -$113K | 0.73% | 36 |
|
|
2017
Q1 | $1.66M | Buy |
10,812
+144
| +1% | +$22K | 0.69% | 37 |
|
|
2016
Q4 | $1.51M | Sell |
10,668
-248
| -2% | -$36.6K | 0.67% | 44 |
|
|
2016
Q3 | $1.74M | Sell |
10,916
-229
| -2% | -$35.3K | 0.74% | 38 |
|
|
2016
Q2 | $1.65M | Buy |
11,145
+510
| +5% | +$75.3K | 0.72% | 37 |
|
|
2016
Q1 | $1.51M | Sell |
10,635
-158
| -1% | -$21.2K | 0.73% | 40 |
|
|
2015
Q4 | $1.53M | Buy |
10,793
+174
| +2% | +$23.2K | 0.76% | 37 |
|
|
2015
Q3 | $1.3M | Buy |
10,619
+80
| +0.8% | +$10.4K | 0.74% | 40 |
|
|
2015
Q2 | $1.37M | Buy |
10,539
+657
| +7% | +$85.7K | 0.69% | 39 |
|
|
2015
Q1 | $1.33M | Sell |
9,882
-22
| -0.2% | -$2.84K | 0.67% | 39 |
|
|
2014
Q4 | $1.24M | Buy |
+9,904
| New | +$1.2M | 0.75% | 35 |
|
Other funds holding TMO
VCM
Argent Trust Co's TMO Position: Q1 2026 in Review
Argent Trust Co increased its Thermo Fisher Scientific (TMO) stake by 8.4% in Q1 2026, buying an estimated $1.05M and bringing the position to 25,095 shares worth $12.3M. The position accounts for 0.42% of the portfolio, ranked #53.
Argent Trust Co first reported a position in TMO in Q4 2014 and has held it in 46 quarters since. The position peaked at $14M in Q3 2024. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Argent Trust Co held 25,095 shares of Thermo Fisher Scientific worth $12.3M as of Q1 2026.
- Argent Trust Co bought 1,943 Thermo Fisher Scientific shares in Q1 2026, an estimated $1.05M.
- Thermo Fisher Scientific made up 0.42% of Argent Trust Co's portfolio in Q1 2026, its #53 holding.
- Argent Trust Co first reported a position in Thermo Fisher Scientific in Q4 2014 and has held it in 46 quarters since.
- Argent Trust Co's Thermo Fisher Scientific position peaked at $14M in Q3 2024.
- 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Argent Trust Co's 13F filing for Q1 2026, filed 13 May 2026.